Anirvan Ghosh, Unity Biotechnology CEO (Biogen via Facebook)
November 1, 2022 07:05 AM EDTUpdated 07:22 AM
R&D

A sin­gle in­jec­tion of Uni­ty's an­ti-ag­ing hy­poth­e­sis bears fruit in PhII, as piv­otal plans shape up

Kyle LaHucik

Senior Reporter

We all know the scene. Jamie Lee Cur­tis’ char­ac­ter in “Freaky Fri­day” pens a book ti­tled “Through the Look­ing Glass: Senes­cence in Ret­ro­grade,” and she …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times